The role of histologic remission as disease clearance: Emerging treat‐to‐target in pediatric ulcerative colitis
OBJECTIVES: While clinical and endoscopic remission (ER) are established therapeutic targets in ulcerative colitis (UC), endoscopic healing may not fully reflect residual microscopic inflammation. Histologic remission (HR) has been proposed as a deeper marker of disease control and a potential predictor of long-term outcomes. We evaluated whether HR predicts relapses in pediatric UC patients who achieved ER. METHODS: This multicenter retrospective cohort study included pediatric patients with UC (<18 years) who achieved ER (Mayo endoscopic subscore (MES) 0 or 1). HR was defined as a Nancy index score of 0. Patients were stratified into HR and non-HR groups. The primary outcome was clinical relapse, defined as a partial Mayo score ≥3, corticosteroid initiation, requiring treatment escalation, UC-related hospitalization, colectomy or death. Relapse-free survival was analyzed using Kaplan-Meier estimates and Cox proportional hazards models. RESULTS: Among 111 pediatric UC patients with ER, 35 (31.5%) achieved HR. Patients with HR showed significantly improved relapse-free survival than non-HR (log-rank p = 0.015). Multivariable Cox regression demonstrated that both ER (MES 0 vs. 1; hazard ratio 0.57, 95% confidence interval (CI) 0.28-0.94, p = 0.032) and HR (hazard ratio 0.39, 95% CI 0.17-0.91, p = 0.030) independently predicted reduced relapse risk. Notably, even among patients with ER, those with a Nancy index of 0 had superior relapse-free survival versus a score of 1 (p = 0.008). CONCLUSIONS: HR was achieved in only one-third of pediatric patients with UC with ER but was strongly associated with reduced relapse, supporting HR as a treatment target beyond ER.
Authors
- Yiyoung Kwon (ORCID: https://orcid.org/0000-0001-5600-2070)
- Tae Jong Jeong (ORCID: https://orcid.org/0000-0002-6221-4149)
- Yon Ho Choe (ORCID: https://orcid.org/0000-0003-1525-7688)
- Yoon Zi Kim (ORCID: https://orcid.org/0000-0002-1568-3364)
- Eun Sil Kim (ORCID: https://orcid.org/0000-0003-2012-9867)
- Mi Jin Kim (ORCID: https://orcid.org/0000-0002-4505-4083)
Institutions
- Samsung Medical Center (KR)
- Kangbuk Samsung Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1002/jpn3.70685
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Samsung